FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
EXPEDITED DEVELOPMENT AND REVIEW INIATIVES - FDA PERSPECTIVE
EXPEDITED DEVELOPMENT AND REVIEW: 4 MAJOR INITIATIVES
NEW DRUG DEVELOPMENT
FDAMA Section 112
Components (4 parts)
FAST TRACK PROGRAM: FIRST QUESTIONS
PPT Slide
FAST TRACK
ROLLING REVIEW
EXPERIENCE in 1st YEAR
SELECTED INDICATIONS
SUMMARY
Murray M. Lumpkin, M.D., Deputy Center Director, Center for Drug Evaluation and Research, US Food and Drug Administration
Download presentation source
Last update: July 11, 2005
CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research
